LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Lowering Zenas BioPharma, Inc. (ZBIO) Q1 26 Estimate To -1.54 From -1.36 10/9/2025 8:04:49 AM
  • Wedbush Is Cutting Zenas BioPharma, Inc. (ZBIO) FY 25 Estimate To -2.95 From 1.37 10/9/2025 8:04:17 AM
  • Wedbush Is Lowering Zenas BioPharma, Inc. (ZBIO) Q4 25 Estimate To -0.71 From 1.49 10/9/2025 8:04:02 AM
  • Wedbush Is Cutting Zenas BioPharma, Inc. (ZBIO) Q3 25 Estimate To -0.27 From 1.91 10/9/2025 8:03:46 AM
  • Wedbush Reiterates Zenas BioPharma, Inc. (ZBIO) At Outperform With $40 Up From $35 Price Target 10/9/2025 8:03:08 AM
  • Royalty Pharma To Fund Up To $300 Mln For Zenas’ Obexelimab Program In Exchange For Sales Royalties 9/2/2025 7:30:05 AM
  • Zenas BioPharma Q2 Net Loss/shr $1.25 Vs. Loss/shr $24.23 Last Year 8/12/2025 7:09:48 AM
  • Wedbush Is Raising Zenas BioPharma, Inc. (ZBIO) FY26 Estimate To -4.00 From -4.43 5/15/2025 4:59:47 PM
  • Wedbush Is Increasing Zenas BioPharma, Inc. (ZBIO) Q4 26 Estimate To -0.97 From -1.08 5/15/2025 4:59:33 PM
  • Wedbush Is Increasing Zenas BioPharma, Inc. (ZBIO) Q3 26 Estimate To -0.96 From -1.07 5/15/2025 4:59:23 PM
  • Wedbush Is Raising Zenas BioPharma, Inc. (ZBIO) Q2 26 Estimate To -1.05 From -1.15 5/15/2025 4:59:11 PM
  • Wedbush Is Raising Zenas BioPharma, Inc. (ZBIO) Q1 26 Estimate To -1.04 From -1.14 5/15/2025 4:59:00 PM
  • Wedbush Is Raising Zenas BioPharma, Inc. (ZBIO) FY25 Estimate To -3.79 From -4.33 5/15/2025 4:58:50 PM
  • Wedbush Is Raising Zenas BioPharma, Inc. (ZBIO) Q4 25 Estimate To -0.92 From -1.02 5/15/2025 4:58:40 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap